SDHD and cutaneous melanoma: Scholz et al reported 4% of SDHD promoter mutations in a cohort of cutaneous melanomas, but not related with clinico-pathologic factors or patient survival, and no mutations were found in ocular, mucosal and occult melanomas [9].